Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions. - See more at: http://www.gilead.com/about#sthash.rpDd6mCW.dpuf

Research Grants 13 show all


$480.7K
2007

$491.8K
2008

$493.3K
2009

$14.1M
2010

$1.9M
2016

Patents 8,541show all

4,390Applications2,939Issued

Clinical Trials 785show all

206Phase 2183Phase 3114Phase 499Phase 160N/A41Other

SEC Filings show all


214
8-K

69
10-Q

18
10-K

1
D

Contact Information

Foster City, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2006-04-03UnknownUnknownOther (Paper Filing)